Intelligence · Clinical pipeline
Oncology R&D Pipeline
Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Quick answer
Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.
Top sponsors
- First People's Hospital 474 programs
- Chinese Academy of 400 programs
- United Therapeutics Europe 219 programs
- George Institute for 172 programs
- Takeda 163 programs
- HOFFMANN-LA ROCHE 144 programs
- AstraZeneca 143 programs
- MSD Merck Sharp 131 programs
- Regeneron UK 128 programs
- Anaxis Pharma 125 programs
- Telethon Foundation 113 programs
- Novartis India 110 programs
Pipeline programs
-
Pevonedistat-2002
Takeda
Acute Myeloid Leukemia
1 trial -
Pexastimogene Devacirepvec (Pexa-Vec)
Regeneron UK Limited
Renal Cell Carcinoma
1 trial -
Ph1 INBRX-109 Part 3
Inhibrx Biosciences
Advanced or metastatic solid tumors
1 trial -
Ph2 INBRX-109 SA CS
Inhibrx Biosciences
Unresectable or metastatic conventional chondrosarcoma
1 trial -
Phase 1/2A Study of OTP-01 for advanced solid tumors
Lacuna Pharma Pty Ltd
advanced solid tumors
1 trial -
Phase 1b/2 trial of 5-fluorouracil for metastatic colorectal cancer
Fondazione Telethon ETS
metastatic colorectal cancer
1 trial -
Phase 1b: APG-115+pembrolizumab
Ascentage Pharma Group
Unresectable or Metastatic Melanoma or Advanced Solid Tumors
1 trial -
Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors
Lacuna Pharma Pty Ltd
Advanced Solid Tumors
1 trial -
Phase I Study of PM534 to Patients with Advanced Solid Tumors
Lacuna Pharma Pty Ltd
Advances solid tumors
1 trial -
Piqray 50 mg and 200 mg film-coated tablets
Wuhan Createrna Science and Technology Co., Ltd
metasatic breast cancer, hormon positive, her 2 negative
1 trial -
Pirarubicin
The First People's Hospital of Lianyungang
Upper Tract Urothelial Carcinoma
1 trial -
Placebo
NovaBridge Biosciences
Breast Cancer
1 trial -
Placebo
Cardiff Oncology
Metastatic Breast Cancer
1 trial -
Placebo
Hospital Authority, Hong Kong
STOMACH NEOPLASM
1 trial -
Pluvicto 1 000 MBq/mL solution for injection/infusion
Ningbo Cancer Hospital
Clear Cell Renal Cell Carcinoma (ccRCC)
1 trial -
Ponatinib
Cardiff Oncology
Acute Lymphoblastic Leukemia, Adult
1 trial -
Ponatinib
Takeda
Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
1 trial -
Ponatinib
Takeda
Chronic Myeloid Leukemia
1 trial -
Ponatinib
Takeda
Myeloid Leukemia, Chronic, Chronic Phase
1 trial -
Postoperative adjuvant lenvatinib
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma (HCC)
1 trial -
Pre-operative chemotherapy
Nanjing Zenshine Pharmaceuticals
Gastric Cancers
1 trial -
Pre-operative chemotherapy
The First People's Hospital of Lianyungang
Non-small Cell Lung Cancer
1 trial -
PreSave
Fondazione Telethon ETS
Muscle-Invasive Bladder cancer
1 trial -
ProSpare
United Therapeutics Europe Ltd
Cancer
1 trial -
Probiotics Compound (Biolosion)
Sun Yat-sen University
Advanced Urothelial Carcinoma
1 trial -
Prodige 54 SAMCO
CERO THERAPEUTICS HOLDINGS, INC.
COLORECTAL METASTATIC CANCER WITH MICROSATELLITE INSTABILITY
1 trial -
Programmed Cell Death Protein 1 Inhibitor
Chinese University of Hong Kong
Locally Advanced Esophageal Squamous Cell Carcinoma
1 trial -
Prostate alone IMRT
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Pucotenlimab
Zhejiang Provincial People's Hospital
Pancreatic Cancer
1 trial -
Pucotenlimab
Sun Yat-sen University
Colorectal Cancer (CRC)
1 trial -
Pulmonary Rehabilitation (PR)
United Therapeutics Europe Ltd
Non-small Cell Lung Cancer Stage III
1 trial -
Pyrotinib
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
QINLOCK 50 mg tablets
Lacuna Pharma Pty Ltd
Advanced gastrointestinal stromal tumor (GIST)
1 trial -
QL1706
The First People's Hospital of Lianyungang
Local Advanced Esophageal Cancer
1 trial -
QL1706
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Platinum-resistant Recurrent Ovarian Cancer
1 trial -
QL1706 (Iparomlimab/Tuvonralimab)
The First People's Hospital of Lianyungang
Gastric Cancer Stage III
1 trial -
QL1706 (bispecific antibody targeting PD-1 and CLTA-4)
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
QL1706-2025-086
The First People's Hospital of Lianyungang
Cervical Cancer Stage IVA
1 trial -
QUILT-2.005
Immunitybio Ireland Limited
Non-Muscle Invasive Bladder Cancer
1 trial -
QUINTIS
The George Institute
Metastatic Colorectal Cancer without liver metastases
1 trial -
Quemliclustat
Arcus Biosciences
Oligometastatic Prostate Cancer
1 trial -
Quizartinib
Daiichi Sankyo
Acute Myeloid Leukemia
1 trial -
R10597-ONC-22114
Lacuna Pharma Pty Ltd
Melanoma, Advanced Solid Tumours, Clear-Cell Renal-Cell Carcinoma (ccRCC)
1 trial -
R1979-ONC-1625
Lacuna Pharma Pty Ltd
B-cell non-Hodgkin lymphoma (NHL)
1 trial -
R2810-ONC-2045
Lacuna Pharma Pty Ltd
Advanced Non-Small Cell Lung Cancer
1 trial -
R2810-ONC-2268
Lacuna Pharma Pty Ltd
Non-Small Cell Lung Cancer
1 trial -
R3767-ONC-2208
Lacuna Pharma Pty Ltd
Melanoma
1 trial -
R3767-ONC-2266
Lacuna Pharma Pty Ltd
Resectable Non-small Cell Lung Cancer
1 trial
Frequently asked questions
How many oncology pipeline programs are tracked?
5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.